BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31406378)

  • 1. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
    Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
    Bagadia P; Huang X; Liu TT; Durai V; Grajales-Reyes GE; Nitschké M; Modrusan Z; Granja JM; Satpathy AT; Briseño CG; Gargaro M; Iwata A; Kim S; Chang HY; Shaw AS; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1174-1185. PubMed ID: 31406377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and functional interaction among Irf8 enhancers during dendritic cell differentiation.
    Yamasaki T; Nishiyama A; Kurogi N; Nishimura K; Nishida S; Kurotaki D; Ban T; Ramilowski JA; Ozato K; Toyoda A; Tamura T
    Cell Rep; 2024 Apr; 43(4):114107. PubMed ID: 38613785
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Liu TT; Ou F; Belk JA; Bagadia P; Anderson DA; Durai V; Yao W; Satpathy AT; Murphy TL; Murphy KM
    Genes Dev; 2023 Apr; 37(7-8):291-302. PubMed ID: 36990511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription Factor IRF8 Governs Enhancer Landscape Dynamics in Mononuclear Phagocyte Progenitors.
    Kurotaki D; Nakabayashi J; Nishiyama A; Sasaki H; Kawase W; Kaneko N; Ochiai K; Igarashi K; Ozato K; Suzuki Y; Tamura T
    Cell Rep; 2018 Mar; 22(10):2628-2641. PubMed ID: 29514092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes.
    Murakami K; Sasaki H; Nishiyama A; Kurotaki D; Kawase W; Ban T; Nakabayashi J; Kanzaki S; Sekita Y; Nakajima H; Ozato K; Kimura T; Tamura T
    Nat Immunol; 2021 Mar; 22(3):301-311. PubMed ID: 33603226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice.
    Kurotaki D; Kawase W; Sasaki H; Nakabayashi J; Nishiyama A; Morse HC; Ozato K; Suzuki Y; Tamura T
    Blood; 2019 Apr; 133(17):1803-1813. PubMed ID: 30796024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8.
    Anderson DA; Ou F; Kim S; Murphy TL; Murphy KM
    J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34958351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
    Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
    Front Immunol; 2019; 10():173. PubMed ID: 30800127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lncRNA identifies
    Xu H; Li Z; Kuo CC; Götz K; Look T; de Toledo MAS; Seré K; Costa IG; Zenke M
    Elife; 2023 Mar; 12():. PubMed ID: 36916882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
    Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
    Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.
    Liu TT; Kim S; Desai P; Kim DH; Huang X; Ferris ST; Wu R; Ou F; Egawa T; Van Dyken SJ; Diamond MS; Johnson PF; Kubo M; Murphy TL; Murphy KM
    Nature; 2022 Jul; 607(7917):142-148. PubMed ID: 35732734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells.
    Sontag S; Förster M; Qin J; Wanek P; Mitzka S; Schüler HM; Koschmieder S; Rose-John S; Seré K; Zenke M
    Stem Cells; 2017 Apr; 35(4):898-908. PubMed ID: 28090699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively.
    Sichien D; Scott CL; Martens L; Vanderkerken M; Van Gassen S; Plantinga M; Joeris T; De Prijck S; Vanhoutte L; Vanheerswynghels M; Van Isterdael G; Toussaint W; Madeira FB; Vergote K; Agace WW; Clausen BE; Hammad H; Dalod M; Saeys Y; Lambrecht BN; Guilliams M
    Immunity; 2016 Sep; 45(3):626-640. PubMed ID: 27637148
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
    Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
    Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
    Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
    Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
    Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation.
    Kurotaki D; Osato N; Nishiyama A; Yamamoto M; Ban T; Sato H; Nakabayashi J; Umehara M; Miyake N; Matsumoto N; Nakazawa M; Ozato K; Tamura T
    Blood; 2013 Mar; 121(10):1839-49. PubMed ID: 23319570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage.
    Lança T; Ungerbäck J; Da Silva C; Joeris T; Ahmadi F; Vandamme J; Svensson-Frej M; Mowat AM; Kotarsky K; Sigvardsson M; Agace WW
    Immunity; 2022 Aug; 55(8):1431-1447.e11. PubMed ID: 35830859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
    Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
    Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.